Hims & Hers Health HIMS Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 71.7%-5.3pp | 73.8%-5.6pp | 75%-6.1pp | 76.2%-6.0pp | 77%-5.4pp | |
| Operating margin | -1.3%-7.5pp | 4.5%+0.3pp | 5.2%+1.7pp | 6.2%+5.1pp | 6.2%+7.0pp | |
| Net margin | -0.6%-9.8pp | 5.5%-3.1pp | 6.1%-2.0pp | 9.6%+8.0pp | 9.2%+9.6pp | |
| EBITDA margin | 1.6%-5.8pp | 6.8%+1.5pp | 7.1%+2.6pp | 7.7%+5.5pp | 7.4%+7.2pp | |
| Free cash flow margin | 11.9%-5.8pp | 12.8%-3.7pp | 13.8%-1.3pp | 13.1%+1.6pp | 17.7%+8.6pp | |
| Returns | ||||||
| Return on equity | -2.7%-39.4pp | 25.2%-5.5pp | 26.2%+0.2pp | 41.9%+36.9pp | 36.8%+37.9pp | |
| Return on assets | -0.8%-25.4pp | 9%-13.0pp | 9.4%-10.2pp | 16.4%+12.5pp | 24.5%+25.4pp | |
| Return on invested capital | -8.5%-45.9pp | 29.1%+5.4pp | 34.5%+19.1pp | —— | 37.4%+40.6pp | |
| Efficiency | ||||||
| Asset turnover | 1.5×-1.2× | 1.6×-0.9× | 1.6×-0.9× | 1.7×-0.7× | 2.7×+0.3× | |
| Inventory turnover | 8.6×+0.9× | 8.5×+1.5× | 7.1×+0.5× | 5.3×-0.9× | 7.7×+1.1× | |
| Liquidity | ||||||
| Current ratio | 1.7×+0.1× | 1.9×+0.1× | 1.9×-0.3× | 5×+2.3× | 1.6×-1.2× | |
| Quick ratio | 1.6×+0.2× | 1.7×+0.2× | 1.6×-0.2× | 4.5×+2.2× | 1.3×-1.2× | |
| Cash ratio | 0.4×-0.6× | 0.6×-0.4× | 0.8×-0.3× | 4.1×+2.9× | 1×-0.2× | |
| Leverage | ||||||
| Debt-to-equity | 0.4×+0.2× | 0.3×+0.2× | 0.3×+0.2× | 0.1×+0.1× | 0.1×+0.1× | |
| Debt-to-assets | 0.1×0.0× | 0.1×+0.1× | 0.1×0.0× | 0×0.0× | 0.1×0.0× | |
| Net debt / EBITDA | -1.7×-0.1× | -0.5×+2.2× | -1.3×+1.5× | -6.8×-1.8× | -1.6×+43.0× | |
| Per Share | ||||||
| Book value per share | $1.95-12.3% | $2.09+4.1% | $2.34+24.8% | $2.19+42.2% | $2.23+48.3% | |
| Valuation | ||||||
| Market capitalization | $4.73B-27.9% | $7.39B+39.9% | $12.82B+224% | $9.61B+123% | $6.56B+98.8% | |
| Enterprise value | $4.67B-26.5% | $7.31B+44.1% | $12.62B+232% | $8.56B+104% | $6.35B+98.1% | |
| Price / sales | 2×-1.7× | 3.1×-0.4× | 5.8×+2.6× | 4.8×+0.7× | 3.7×+0.2× | |
| Price / book | 10.6×-1.3× | 13.7×+2.6× | 22.1×+13.1× | 17.1×+5.2× | 12×+2.4× | |
| EV / EBITDA | 124.2×+76.2× | 45.7×-18.6× | 80.1×+13.0× | 55.3×-122× | 48×-1,471× | |
| EV / sales | 2×-1.6× | 3.1×-0.3× | 5.7×+2.7× | 4.3×+0.3× | 3.6×+0.2× | |
| Free cash flow yield | 6%+1.1pp | 4.1%-0.5pp | 2.4%-2.4pp | 2.7%-0.1pp | 4.8%+2.2pp | |
| Earnings yield | -0.3%-2.8pp | 1.7%-0.6pp | 1%-1.5pp | 2%+1.6pp | 2.5%+2.6pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Hims & Hers Health's profit margins?
- Hims & Hers Health (HIMS) runs a 71.7% gross margin and a -1.3% operating margin, with a -0.6% net margin.
- Where do Hims & Hers Health's ratios come from?
- Every ratio is computed from Hims & Hers Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
